• Explore /
  • Poster
  • / Phase II trial of conversion surgery after apatinib in combination with S-1/oxaliplatin (SOX) for patients with unresectable gastric cancer (Ahead-BG301 trial).

Phase II trial of conversion surgery after apatinib in combination with S-1/oxaliplatin (SOX) for patients with unresectable gastric cancer (Ahead-BG301 trial).

Abstract Poster

Authors

null

Lin Chen

Chinese People’s Liberation Army General Hospital, Beijing, China

Lin Chen , Kecheng Zhang , Bo Wei , Xin Guo , Hongqing Xi , Jiyang Li , Jianxin Cui , Yunhe Gao , Wenquan Liang , Yixun Lu

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2018 Gastrointestinal Cancers Symposium

Session Type

Trials in Progress Poster Session

Session Title

Trials in Progress Poster Session A: Cancers of the Esophagus and Stomach

Track

Cancers of the Esophagus and Stomach

Sub Track

Multidisciplinary Treatment

Clinical Trial Registration Number

NCT03007446

Citation

J Clin Oncol 36, 2018 (suppl 4S; abstr TPS203)

DOI

10.1200/JCO.2018.36.4_suppl.TPS203

Abstract #

TPS203

Poster Bd #

M17

Abstract Disclosures

Similar Posters

First Author: Antonino De Paoli

First Author: Xiangdong Cheng

First Author: Hyung-Don Kim

First Author: Richard Francis Dunne